Allyson De Meulder

In clinical trials, patient safety is paramount and effective supply chain Regulatory inspections and mock recalls are no longer rare events they are ongoing realities for clinical trial supply organisations. This session reframes compliance as a strategic enabler rather than a procedural burden, highlighting how strong compliance practices protect patients, reduce operational risk, and support trial continuity.

Attendees will explore how proactive collaboration with Quality Assurance strengthens inspection readiness and enables faster, more effective responses to recalls and deviations. The session will focus on embedding compliance into day-to-day supply operations, fostering transparency, and building processes that stand up to regulatory scrutiny at any time.

By treating compliance as an integrated partnership rather than a last-minute exercise organizations can move beyond “checkbox compliance” and achieve resilient, auditready clinical trial supply operations.

Key Takeaways

t Learn how embedding compliance into operational workflows reduces inspection stress

t Understand how early and ongoing collaboration with QA drives stronger processes, smoother inspections, and faster recall execution. t Discover best practices for building transparent, well-documented, and audit-ready supply operations